Photobiomodulation for Pain Management

Prof. Praveen Arany is trained as a dentist and an oral pathologist. He has served as an Assistant Clinical Investigator at the National Institute of Dental and Craniofacial Research, NIH, Bethesda, from 2012 to 2015. In 2015, he joined Oral Biology at the School of Dental Medicine, University at Buffalo, New York, and is currently an Associate Professor with tenure. He also has several adjunct positions in various institutes.

He has over 150 scientific publications with several well-cited papers to his credit. His work has been featured in many mainstream media highlights in over 70 countries, including Fox News, CNN, MSNBC, Washington Post, BBC, Reuters, and MIT technical review, among many others. His research is routinely featured in both print and public media.
He has received numerous awards, such as the NCI Director's Young Investigator Award, Wound Healing Society's Young Investigator Award, Eugene Seidner Scholar, and Horrace Furomoto Young Investigator Award. He has been invited to speak in various national and international forums, reviews for over 100 scientific journals, serves on 9 journal editorial boards, is an Associate Editor in 4, and reviews grants for national and international funding agencies.
Dr. Arany has held several leadership positions and continued to serve in various positions in the Wound Healing Society (WHS), American Association for Dental Research (AADR), Academy of Laser Dentistry (ALD), American Society of Lasers in Medicine (ASLMS), American Dental Education Association (ADEA). He is the immediate past president of the World Association for Photobiomodulation Therapy (WALT) and North American Association for Photobiomodulation Therapy (NAALT), Co-Chair of the International Society of Optics and Photonics (SPIE) conference on Mechanisms of Photobiomodulation therapy and Chair, Technical group on Photobiomodulation, Optica, and Co-Director, Center for Excellence in Photobiomodulation in Nursing, West Virginia. Dr. Arany’s contributions to the establishment of the field of Photobiomodulation include: establishing standard nomenclature, demonstrating a novel TFG-beta 1 activation mechanism for tissue regeneration, and outlining clinical/molecular biomarkers and treatment protocols. This has led to clinical guidelines for treating various diseases and promotion wellness, especially in supportive cancer care.